Dr. Richard L. Deming
Claim this profileMercy Medical Center - Des Moines
Expert in Skin Cancer
Expert in Cancer
178 reported clinical trials
242 drugs studied
About Richard L. Deming
Education:
- Obtained MD from Creighton University School of Medicine in 1980.
- Completed Residency in Radiation Oncology at the University of California, San Francisco.
Experience:
- Internship at Naval Medical Center in 1981.
- Served as Medical Director of Mercy Cancer Center and Chairman of the Oncology Service Line at Mercy Medical Center.
- Founder and Chairman of Above + Beyond Cancer, a nonprofit organization.
- Recipient of the Lane Adams Quality of Life Award and the St. George National Award.
- Affiliated with Mercyone Des Moines Medical Center, boasting over 43 years of experience in Radiation Oncology.
Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
Stage I
2Cancer
Global LeaderStage IV
Stage I
Stage III
Affiliated Hospitals
Clinical Trials Richard L. Deming is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Symptom Monitoring
for Young Women on Hormone Therapy
This phase III trial compares the effect of active symptom monitoring and patient education to patient education alone in helping young women with stage I-III breast cancer stay on their hormone therapy medicines. The patient education tool contains interactive weblinks which provide patients with education material about breast cancer and side effects of therapy. Symptom monitoring is a weblink via email or text message with questions asking about symptoms. Hormone therapy for breast cancer can cause side effects, and may cause some women to stop treatment early. Asking about symptoms more often may help women keep taking hormone therapy medicines.
Recruiting1 award N/A13 criteria
More about Richard L. Deming
Clinical Trial Related6 years of experience running clinical trials · Led 178 trials as a Principal Investigator · 97 Active Clinical TrialsTreatments Richard L. Deming has experience with
- Nivolumab
- Carboplatin
- Cisplatin
- Atezolizumab
- Paclitaxel
- Pembrolizumab
Breakdown of trials Richard L. Deming has run
Skin Cancer
Cancer
Breast Cancer
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Richard L. Deming specialize in?
Richard L. Deming focuses on Skin Cancer and Cancer. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are Stage III.
Is Richard L. Deming currently recruiting for clinical trials?
Yes, Richard L. Deming is currently recruiting for 93 clinical trials in Des Moines Iowa. If you're interested in participating, you should apply.
Are there any treatments that Richard L. Deming has studied deeply?
Yes, Richard L. Deming has studied treatments such as Nivolumab, Carboplatin, Cisplatin.
What is the best way to schedule an appointment with Richard L. Deming?
Apply for one of the trials that Richard L. Deming is conducting.
What is the office address of Richard L. Deming?
The office of Richard L. Deming is located at: Mercy Medical Center - Des Moines, Des Moines, Iowa 50314 United States. This is the address for their practice at the Mercy Medical Center - Des Moines.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.